View in EDS

Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study'.

Saved in:
Bibliographic Details
Title: Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study'.
Authors: Stephan C; Department of Internal Medicine 2, Infectious Diseases Unit, University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Albuquerque B; Gilead Sciences GmbH, Martinsried, Germany., Schreiber S; Gilead Sciences GmbH, Martinsried, Germany.
Source: HIV medicine [HIV Med] 2026 Feb; Vol. 27 (2), pp. 324-325. Date of Electronic Publication: 2025 Dec 01.
Publication Type: Letter
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41327554
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study'.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stephan+C%22">Stephan C</searchLink>; Department of Internal Medicine 2, Infectious Diseases Unit, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Albuquerque+B%22">Albuquerque B</searchLink>; Gilead Sciences GmbH, Martinsried, Germany.<br /><searchLink fieldCode="AU" term="%22Schreiber+S%22">Schreiber S</searchLink>; Gilead Sciences GmbH, Martinsried, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100897392%22">HIV medicine</searchLink> [HIV Med] 2026 Feb; Vol. 27 (2), pp. 324-325. <i>Date of Electronic Publication: </i>2025 Dec 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100897392 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-1293 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214642662%22">14642662 </searchLink><i>NLM ISO Abbreviation: </i>HIV Med <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41327554
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/hiv.70159
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 324
    Titles:
      – TitleFull: Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study'.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stephan C
      – PersonEntity:
          Name:
            NameFull: Albuquerque B
      – PersonEntity:
          Name:
            NameFull: Schreiber S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1468-1293
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: HIV medicine
              Type: main
ResultId 1